S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up
S&P 500   4,164.00
DOW   34,156.69
QQQ   309.88
Two Billionaires Are Rigging the Market. Here’s How to Fight Back
The #1 Energy Stock to Buy (Ad)
3 Hot Stocks The Analysts Are Buying 
Is Biotech Immunocore About To Make A 25% Price Move?
The #1 Energy Stock to Buy (Ad)
Why Is Wall Street Loving Amazon So Much? 
Want to Invest in ChatGPT? Then Buy Microsoft Stock
The #1 Energy Stock to Buy (Ad)
Stocks end higher after zig-zagging on Fed chair's comments
Patient Clorox Shareholders Are Cleaning Up

Merit Medical Systems - MMSI Stock Forecast, Price & News

$71.61
+0.29 (+0.41%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$69.93
$72.64
50-Day Range
$68.16
$74.43
52-Week Range
$50.46
$76.14
Volume
253,105 shs
Average Volume
269,452 shs
Market Capitalization
$4.08 billion
P/E Ratio
66.31
Dividend Yield
N/A
Price Target
$73.50

Merit Medical Systems MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
2.6% Upside
$73.50 Price Target
Short Interest
Healthy
1.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
1.67mentions of Merit Medical Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.73%
From $2.57 to $2.82 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Medical Sector

423rd out of 1,029 stocks

Surgical & Medical Instruments Industry

44th out of 105 stocks

MMSI stock logo

About Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Stock News Headlines

The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Syneos Health (SYNH) to Launch Serplulimab With New Pact
Stock Eyeing 261% Growth This Year Sets Up New Buy Point
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Merit Medical Launches the basixALPHA™ Inflation Device
MMSI vs. CNMD: Which Stock Should Value Investors Buy Now?
PacBio's (PACB) Q3 Earnings Top Estimates, Revenues Lag
LHC Group's (LHCG) Q3 Earnings & Revenues Miss Estimates
Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Company Calendar

Last Earnings
10/28/2021
Today
2/07/2023
Next Earnings (Confirmed)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,446
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$73.50
High Stock Price Forecast
$78.00
Low Stock Price Forecast
$72.00
Forecasted Upside/Downside
+2.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$48.45 million
Pretax Margin
6.40%

Debt

Sales & Book Value

Annual Sales
$1.07 billion
Cash Flow
$4.02 per share
Book Value
$18.42 per share

Miscellaneous

Free Float
54,756,000
Market Cap
$4.08 billion
Optionable
Optionable
Beta
0.99

Social Links


Key Executives

  • Fred P. LampropoulosFred P. Lampropoulos
    Chairman, President & Chief Executive Officer
  • Neil Peterson
    Chief Operating Officer
  • Raul ParraRaul Parra
    Chief Financial Officer & Treasurer
  • Joseph Pierce
    Chief Information Officer
  • Jason Treft
    Chief Technology Officer













MMSI Stock - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price forecast for 2023?

5 brokerages have issued 1 year target prices for Merit Medical Systems' shares. Their MMSI share price forecasts range from $72.00 to $78.00. On average, they anticipate the company's stock price to reach $73.50 in the next year. This suggests a possible upside of 2.6% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2023?

Merit Medical Systems' stock was trading at $70.62 at the beginning of the year. Since then, MMSI shares have increased by 1.4% and is now trading at $71.61.
View the best growth stocks for 2023 here
.

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our MMSI earnings forecast
.

How can I listen to Merit Medical Systems' earnings call?

Merit Medical Systems will be holding an earnings conference call on Wednesday, February 22nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings results on Thursday, October, 28th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.08. The medical instruments supplier earned $267.02 million during the quarter, compared to analysts' expectations of $260.61 million. Merit Medical Systems had a net margin of 5.43% and a trailing twelve-month return on equity of 14.14%. The firm's quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.42 EPS.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.65%), Emerald Advisers LLC (0.92%), Emerald Mutual Fund Advisers Trust (0.72%), Fisher Asset Management LLC (0.47%), New York State Common Retirement Fund (0.40%) and Fort Washington Investment Advisors Inc. OH (0.39%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Neil Peterson, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $71.61.

How much money does Merit Medical Systems make?

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $4.08 billion and generates $1.07 billion in revenue each year. The medical instruments supplier earns $48.45 million in net income (profit) each year or $1.08 on an earnings per share basis.

How many employees does Merit Medical Systems have?

The company employs 6,446 workers across the globe.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.

This page (NASDAQ:MMSI) was last updated on 2/8/2023 by MarketBeat.com Staff